Abstracts tagged "outcomes and spondylarthritis"

Abstract Number: 640 • 2017 ACR/ARHP Annual Meeting
Is There a Relationship between Spondyloarthritis and Periodontitis? a Case-Control Study
Wilson Bautista-Molano¹, Désirée van der Heijde², Robert B.M. Landewé³, Gloria Lafaurie⁴, Julieth De Avila⁴, Rafael Valle-Oñate⁵ and Consuelo Romero-Sanchez⁶, ¹School of Medicine, Universidad Militar Nueva Granada and Rheumatology Department Hospital Militar, Colombia, Bogotá, Colombia, ²Leiden University Medical Center, Leiden, Netherlands, ³University of Amsterdam and Atrium Medical Center, Amsterdam, Netherlands, ⁴Unit of Oral Basic Investigation-UIBO, School of Dentistry, Universidad El Bosque, Colombia, Bogotá, Colombia, ⁵School of Medicine, Universidad Militar Nueva Granada and Rheumatology Department Hospital Militar, Colombia, Bogota, Colombia, ⁶Unit of Oral Basic Investigation-UIBO, School of Dentistry, Universidad El Bosque, Colombia, BOGOTA, Colombia
Background/Purpose: Knowledge of the existence of an epidemiological association between SpA and periodontitis may fuel pathophysiological thinking about SpA and if established, have clinical implications.…
Abstract Number: 2497 • 2017 ACR/ARHP Annual Meeting
The Role of Individual and Country-Level Socio-Economic Factors in Work Participation in Patients with Spondyloarthritis across 22 Countries Worldwide: Results from the Comospa Study
Santiago Rodrigues Manica^1,2, Alexandre Sepriano^3,4, Sofia Ramiro^5,6, Fernando Pimentel-Santos^1,2, Polina Putrik⁷, Elena Nikiphorou^8,9, Anna Moltó^10,11, Maxime Dougados^11,12, Désirée van der Heijde¹³, Robert B.M. Landewé¹⁴, Filip van Den Bosch¹⁵ and Annelies Boonen⁷, ¹CEDOC, NOVA Medical School, Lisbon, Portugal, ²Rheumatology, Hospital Egas Moniz, Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal, ³CEDOC, NOVA Medical School, Lisboa, Portugal, ⁴Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁵Rheumatology, Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, ⁶R. Câmara Pestana 6, CEDOC, NOVA Medical School, Lisbon, Portugal, ⁷MUMC+, Maastricht, Maastricht, Netherlands, ⁸Whittington Hospital, London, United Kingdom, ⁹Academic Rheumatology Department, King's College London, London, United Kingdom, ¹⁰Rheumatology B Department, Paris Descartes University, Cochin Hospital, AP-HP,Paris, Paris, France, ¹¹7 INSERM (U1153), Clinical Epidemiology and Biostatistics, PRES Sorbonne Paris-Cité, Paris, France, ¹²Paris, Paris, France, ¹³Leiden University Medical Center, Leiden, Netherlands, ¹⁴Clinical Immunology & Rheumatology, Academic Medical Center, University of Amsterdam and Atrium Medical Center, Heerlen, Netherlands, ¹⁵Rheumatology, Ghent University Hospital, Gent, Belgium
Background/Purpose: Spondyloarthritis (SpA) carries substantial financial costs, including direct costs (use of medical services and treatments) and indirect costs (loss of work productivity). While disease…
Abstract Number: 1060 • 2015 ACR/ARHP Annual Meeting
The View of Healthy Persons on the Impact of Spondyloarthritis on Functioning and Health: Results of a Best-Worst Scaling Based on the ASAS Health Index
Ivette Essers^1,2, Mickaël Hiligsmann³, Uta Kiltz⁴, Nick Bansback⁵, Juergen Braun⁴, Désirée van der Heijde⁶ and Annelies Boonen^1,7, ¹School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, ²Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Department of Health Services Research, University of Maastricht, Maastricht, Netherlands, ⁴Rheumazentrum Ruhrgebiet, Herne, Germany, ⁵School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁷Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose: The ASAS Health Index (HI) is a disease-specific questionnaire (QoL) for patients with spondyloarthritis (SpA) aiming to measure functioning and health. The ASAS HI…
Abstract Number: 2332 • 2015 ACR/ARHP Annual Meeting
Deriving ‘population References’ of Health Utilities for Patients with Spondyloarthritis Based on the ASAS Health Index
Ivette Essers^1,2, Mickaël Hiligsmann³, Uta Kiltz⁴, Nick Bansback⁵, Juergen Braun⁴, Désirée van der Heijde⁶ and Annelies Boonen^1,7, ¹School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, Netherlands, ²Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, ³Department of Health Services Research, University of Maastricht, Maastricht, Netherlands, ⁴Rheumazentrum Ruhrgebiet, Herne, Germany, ⁵School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada, ⁶Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ⁷Maastricht University Medical Center, Maastricht, Netherlands
Background/Purpose: The ASAS Health Index (HI) was developed to assess the impact of spondyloarthritis (SpA) on the patients' overall function and health. Utilities are a…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].